Gabapentin Dementia Lawsuit in Ohio - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Ohio is the epicenter of gabapentin litigation concerns, combining the nation's most severe opioid crisis with early controlled substance scheduling and some of the highest gabapentin prescribing rates in the country. Ohio classified gabapentin as a Schedule V controlled substance in 2017, driven by alarming data showing gabapentin present in 22 percent of opioid-related overdose deaths in the state. The scheduling decision acknowledged what Pfizer had long minimized: gabapentin has significant misuse potential and physiological effects that warrant monitoring. Ohio's industrial heartland — Appalachian coal country, Rust Belt manufacturing cities, and agricultural regions — produces chronic pain rates far above national averages, driving massive gabapentin prescribing volumes. The state's experienced mass tort judiciary, particularly in Cuyahoga County (Cleveland) and Hamilton County (Cincinnati), and the Northern District of Ohio's role in the federal opioid MDL, make Ohio one of the most significant jurisdictions for gabapentin cognitive decline litigation.

Written By

People's Justice Legal Research Team

Statute of Limitations

Ohio: 2 years for product liability (Ohio Rev. Code § 2305.10). Discovery rule applies — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to gabapentin.

2 years from discovery of injury

Filing Venue

Where to File in Ohio

Ohio gabapentin cases may be filed in the Northern District (Cleveland, Akron, Toledo, Youngstown) or Southern District (Columbus, Cincinnati, Dayton). The Northern District of Ohio managed the landmark federal opioid MDL (In re: National Prescription Opiate Litigation), giving it unparalleled experience with pharmaceutical mass tort litigation. Cuyahoga County Court of Common Pleas in Cleveland and Hamilton County in Cincinnati handle complex state court pharmaceutical claims. Ohio follows modified comparative fault with a 50% bar. The state caps non-economic damages in personal injury (Ohio Rev. Code § 2315.18) but these caps have exceptions for catastrophic injuries.

Ohio Data

Exposure in Ohio

Source: IQVIA / OARRS PDMP data

Source: Ohio Board of Pharmacy / N.D. Ohio opioid MDL

Source: Ohio Department of Health / Board of Pharmacy analysis

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview